Trimethobenzamide HCl 200 mg / benzocaine 2 % Rectal Suppository
RxNorm 860745
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 860745 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: trimethobenzamide HCl 200 mg / benzocaine 2 % Rectal Suppository.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Benzocaine 0.02 mg/MG / trimethobenzamide hydrochloride 200 mg Rectal Suppository
(Atom ID: 12330372)
PT
Designated preferred name (PT):
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository
(Atom ID: 11435454)
FN
Full form of descriptor (FN):
Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg/1 each conventional release rectal suppository (clinical drug)
(Atom ID: 11439312)
PSN